Correlation Between Zenas BioPharma, and Zillow Group

Can any of the company-specific risk be diversified away by investing in both Zenas BioPharma, and Zillow Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenas BioPharma, and Zillow Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zenas BioPharma, Common and Zillow Group Class, you can compare the effects of market volatilities on Zenas BioPharma, and Zillow Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenas BioPharma, with a short position of Zillow Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenas BioPharma, and Zillow Group.

Diversification Opportunities for Zenas BioPharma, and Zillow Group

0.03

Correlation Coefficient

Zenas BioPharma,  Zillow Group

Significant diversification

The 3 months correlation between Zenas and Zillow is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Zenas BioPharma, Common and Zillow Group Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zillow Group Class and Zenas BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenas BioPharma, Common are associated (or correlated) with Zillow Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zillow Group Class has no effect on the direction of Zenas BioPharma, i.e., Zenas BioPharma, and Zillow Group go up and down completely randomly.

Pair Corralation between Zenas BioPharma, and Zillow Group

Given the investment horizon of 90 days Zenas BioPharma, Common is expected to generate 2.18 times more return on investment than Zillow Group. However, Zenas BioPharma, is 2.18 times more volatile than Zillow Group Class. It trades about -0.03 of its potential returns per unit of risk. Zillow Group Class is currently generating about -0.24 per unit of risk. If you would invest  757.00  in Zenas BioPharma, Common on December 10, 2024 and sell it today you would lose (51.00) from holding Zenas BioPharma, Common or give up 6.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Zenas BioPharma, Common  vs.  Zillow Group Class

Zenas BioPharma, Common

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zenas BioPharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Etf's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the ETF investors.

Zillow Group Class

Risk-Adjusted Performance

Very Weak

Over the last 90 days Zillow Group Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Etf's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Pair Trading with Zenas BioPharma, and Zillow Group

The main advantage of trading using opposite Zenas BioPharma, and Zillow Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenas BioPharma, position performs unexpectedly, Zillow Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zillow Group will offset losses from the drop in Zillow Group's long position.

The idea behind Zenas BioPharma, Common and Zillow Group Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.